617 related articles for article (PubMed ID: 7544439)
1. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
Knowles MR; Hohneker KW; Zhou Z; Olsen JC; Noah TL; Hu PC; Leigh MW; Engelhardt JF; Edwards LJ; Jones KR
N Engl J Med; 1995 Sep; 333(13):823-31. PubMed ID: 7544439
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis.
Knowles MR; Noone PG; Hohneker K; Johnson LG; Boucher RC; Efthimiou J; Crawford C; Brown R; Schwartzbach C; Pearlman R
Hum Gene Ther; 1998 Jan; 9(2):249-69. PubMed ID: 9472784
[TBL] [Abstract][Full Text] [Related]
3. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.
Porteous DJ; Dorin JR; McLachlan G; Davidson-Smith H; Davidson H; Stevenson BJ; Carothers AD; Wallace WA; Moralee S; Hoenes C; Kallmeyer G; Michaelis U; Naujoks K; Ho LP; Samways JM; Imrie M; Greening AP; Innes JA
Gene Ther; 1997 Mar; 4(3):210-8. PubMed ID: 9135734
[TBL] [Abstract][Full Text] [Related]
4. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
Knowles MR; Paradiso AM; Boucher RC
Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.
Gill DR; Southern KW; Mofford KA; Seddon T; Huang L; Sorgi F; Thomson A; MacVinish LJ; Ratcliff R; Bilton D; Lane DJ; Littlewood JM; Webb AK; Middleton PG; Colledge WH; Cuthbert AW; Evans MJ; Higgins CF; Hyde SC
Gene Ther; 1997 Mar; 4(3):199-209. PubMed ID: 9135733
[TBL] [Abstract][Full Text] [Related]
6. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
[TBL] [Abstract][Full Text] [Related]
7. Modification of nasal epithelial potential differences of individuals with cystic fibrosis consequent to local administration of a normal CFTR cDNA adenovirus gene transfer vector.
Hay JG; McElvaney NG; Herena J; Crystal RG
Hum Gene Ther; 1995 Nov; 6(11):1487-96. PubMed ID: 8573621
[TBL] [Abstract][Full Text] [Related]
8. Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis.
Noone PG; Hohneker KW; Zhou Z; Johnson LG; Foy C; Gipson C; Jones K; Noah TL; Leigh MW; Schwartzbach C; Efthimiou J; Pearlman R; Boucher RC; Knowles MR
Mol Ther; 2000 Jan; 1(1):105-14. PubMed ID: 10933918
[TBL] [Abstract][Full Text] [Related]
9. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis.
Hyde SC; Southern KW; Gileadi U; Fitzjohn EM; Mofford KA; Waddell BE; Gooi HC; Goddard CA; Hannavy K; Smyth SE; Egan JJ; Sorgi FL; Huang L; Cuthbert AW; Evans MJ; Colledge WH; Higgins CF; Webb AK; Gill DR
Gene Ther; 2000 Jul; 7(13):1156-65. PubMed ID: 10918483
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
Zabner J; Couture LA; Gregory RJ; Graham SM; Smith AE; Welsh MJ
Cell; 1993 Oct; 75(2):207-16. PubMed ID: 7691415
[TBL] [Abstract][Full Text] [Related]
11. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
12. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans.
Grubb BR; Pickles RJ; Ye H; Yankaskas JR; Vick RN; Engelhardt JF; Wilson JM; Johnson LG; Boucher RC
Nature; 1994 Oct; 371(6500):802-6. PubMed ID: 7523956
[TBL] [Abstract][Full Text] [Related]
13. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.
Alton EW; Stern M; Farley R; Jaffe A; Chadwick SL; Phillips J; Davies J; Smith SN; Browning J; Davies MG; Hodson ME; Durham SR; Li D; Jeffery PK; Scallan M; Balfour R; Eastman SJ; Cheng SH; Smith AE; Meeker D; Geddes DM
Lancet; 1999 Mar; 353(9157):947-54. PubMed ID: 10459902
[TBL] [Abstract][Full Text] [Related]
14. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice.
Jiang C; Akita GY; Colledge WH; Ratcliff RA; Evans MJ; Hehir KM; St George JA; Wadsworth SC; Cheng SH
Hum Gene Ther; 1997 Apr; 8(6):671-80. PubMed ID: 9113507
[TBL] [Abstract][Full Text] [Related]
15. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
Zabner J; Ramsey BW; Meeker DP; Aitken ML; Balfour RP; Gibson RL; Launspach J; Moscicki RA; Richards SM; Standaert TA
J Clin Invest; 1996 Mar; 97(6):1504-11. PubMed ID: 8617884
[TBL] [Abstract][Full Text] [Related]
16. Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium.
Welsh MJ; Smith AE; Zabner J; Rich DP; Graham SM; Gregory RJ; Pratt BM; Moscicki RA
Hum Gene Ther; 1994 Feb; 5(2):209-19. PubMed ID: 7514450
[No Abstract] [Full Text] [Related]
17. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
18. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
Yei S; Mittereder N; Wert S; Whitsett JA; Wilmott RW; Trapnell BC
Hum Gene Ther; 1994 Jun; 5(6):731-44. PubMed ID: 7948135
[TBL] [Abstract][Full Text] [Related]
19. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
Brody SL; Metzger M; Danel C; Rosenfeld MA; Crystal RG
Hum Gene Ther; 1994 Jul; 5(7):821-36. PubMed ID: 7526901
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
